HOSOKAWAMICRON CORPORATION
- Industries & Machines Industries & Machines
- IIoT IIoT
- Service-Toll Processing Service-Toll Processing
- Material Material
- News News
- IR Information IR Information
-
Sustainability
Sustainability
Sustainability
- Introduction
- Sustaibality Policy - Mission Statement
- Editorial Policy
- Integrated Report
- Materiality & Strategy
- Technological contribution to a sustainable global environment
- Contributions towards a safer, more secure and prosperous society
- Sophistication of governance that supports business
- ESG Data Collection
- Sustainable Business Management ~ Finance
- Infromation Disclosure Based on TCFD Recommendations
- Jobs and Careers Jobs and Careers
-
About Us
About Us
About Us
- Management Philosophy
- Greetings (Company Introduction)
- Corporate Overview
- Corporate Profile
- Business Areas and Strengths
- Corporate History
- Hosokawa Micron Group
- Domestic Facilities
- Overseas Subsidiaries (Asia)
- Overseas Subsidiaries (Europe)
- Overseas Subsidiaries (America)
- Asian Agents
- Powder Technology Research Institute
- Industrial Property Rights
- Journals and Books
- Technical Information
- Annual Publication "Micromeritics"
- Compliance Charter
- Privacy Policy
- Cookie Policy
- Quality Principle
Sustainability
Sustainability
Sustainability
Sustainability
- Introduction
- Sustaibality Policy - Mission Statement
- Editorial Policy
- Integrated Report
- Materiality & Strategy
- Technological contribution to a sustainable global environment
- Contributions towards a safer, more secure and prosperous society
- Sophistication of governance that supports business
- ESG Data Collection
- Sustainable Business Management ~ Finance
- Infromation Disclosure Based on TCFD Recommendations
Health & Medical
Initiatives Related to Pharmaceutical Products
In the development of easy-to-administer formulations for an aging society, recent years have seen an increase in the number of drugs that are difficult to dissolve, and improving solubility has become a major Research and Development challenge.
NOB-MINI (approx. 20ml) for R&DOur dry particle composing technology can be used for this purpose by coating the drug, which has been pulverized or crushed by complex processes , on the core particles. Problems such as lumps that prevent dissolution can be solved, and by coating the surface of insoluble drugs with sugar, the amount and speed of dissolution can be increased. We are promoting the development of this technology in the pharmaceutical industry.ト